NO20043023L - Substituerte fenylpropionsyre-derivater som agonister mot human proliferator-aktivert reseptor alfa (PPAR) - Google Patents

Substituerte fenylpropionsyre-derivater som agonister mot human proliferator-aktivert reseptor alfa (PPAR)

Info

Publication number: NO20043023L
Authority: NO; Norway
Prior art keywords: proliferator; ppar; acid derivatives; against human; activated receptor
Prior art date: 2001-12-19

Application number

NO20043023A

Other languages

English (en)

Inventor

Eva-Lotte Alstermark Lindstedt

Lanna Li

Anna Christina Olsson

Original Assignee

Astrazeneca Ab Global Ip

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-19

Filing date

2004-07-15

Publication date

2004-07-15

2004-07-15 Application filed by Astrazeneca Ab Global Ip filed Critical Astrazeneca Ab Global Ip

2004-07-15 Publication of NO20043023L publication Critical patent/NO20043023L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
- C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Endocrinology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Gynecology & Obstetrics (AREA)
Ophthalmology & Optometry (AREA)
Psychiatry (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Pregnancy & Childbirth (AREA)
Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20043023A 2001-12-19 2004-07-15 Substituerte fenylpropionsyre-derivater som agonister mot human proliferator-aktivert reseptor alfa (PPAR) NO20043023L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0104334A SE0104334D0 (sv)	2001-12-19	2001-12-19	Therapeutic agents
PCT/GB2002/005738 WO2003051821A1 (en)	2001-12-19	2002-12-18	Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar)

Publications (1)

Publication Number	Publication Date
NO20043023L true NO20043023L (no)	2004-07-15

Family

ID=20286433

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO20043023A NO20043023L (no)	2001-12-19	2004-07-15	Substituerte fenylpropionsyre-derivater som agonister mot human proliferator-aktivert reseptor alfa (PPAR)
NO20043164A NO20043164L (no)	2001-12-19	2004-07-16	Substituerte fenylpropionsyre-derivater som agonister mot human peroksisom-proliferator-aktivert reseptor alfa (PPAR)

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO20043164A NO20043164L (no)	2001-12-19	2004-07-16	Substituerte fenylpropionsyre-derivater som agonister mot human peroksisom-proliferator-aktivert reseptor alfa (PPAR)

Country Status (30)

Country	Link
US (2)	US7514471B2 (no)
EP (2)	EP1458673B1 (no)
JP (4)	JP3784804B2 (no)
KR (2)	KR20040074094A (no)
CN (3)	CN1620423A (no)
AR (2)	AR038045A1 (no)
AT (2)	ATE363466T1 (no)
AU (2)	AU2002366315A1 (no)
BR (2)	BR0214988A (no)
CA (2)	CA2470491A1 (no)
CY (2)	CY1106276T1 (no)
DE (2)	DE60214594T2 (no)
DK (2)	DK1458672T3 (no)
ES (2)	ES2286310T3 (no)
HU (2)	HUP0402022A3 (no)
IL (3)	IL162331A0 (no)
IS (2)	IS7309A (no)
MX (2)	MXPA04006004A (no)
MY (1)	MY132565A (no)
NO (2)	NO20043023L (no)
NZ (2)	NZ533276A (no)
PL (2)	PL370672A1 (no)
PT (2)	PT1458673E (no)
RU (2)	RU2303031C2 (no)
SE (1)	SE0104334D0 (no)
SI (2)	SI1458673T1 (no)
TW (2)	TWI253444B (no)
UA (2)	UA77460C2 (no)
WO (2)	WO2003051821A1 (no)
ZA (2)	ZA200404657B (no)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2364948C (en)	1999-03-05	2011-04-26	The Procter & Gamble Company	C16 unsaturated fp-selective prostaglandins analogs
US20020172693A1 (en)	2000-03-31	2002-11-21	Delong Michell Anthony	Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en)	2000-03-31	2002-01-31	Delong Mitchell Anthony	Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
GB0229931D0 (en)	2002-12-21	2003-01-29	Astrazeneca Ab	Therapeutic agents
GB0314079D0 (en) *	2003-06-18	2003-07-23	Astrazeneca Ab	Therapeutic agents
SE0104333D0 (sv)	2001-12-19	2001-12-19	Astrazeneca Ab	Therapeutic agents
SE0104334D0 (sv) *	2001-12-19	2001-12-19	Astrazeneca Ab	Therapeutic agents
GB0209467D0 (en) *	2002-04-25	2002-06-05	Astrazeneca Ab	Chemical compounds
CN1662487A (zh)	2002-06-19	2005-08-31	伊莱利利公司	酰胺连接基过氧化物酶体增殖物激活受体调节剂
TWI282784B (en)	2002-06-20	2007-06-21	Astrazeneca Ab	Therapeutic agents
FR2848452B1 (fr) *	2002-12-12	2007-04-06	Aventis Pharma Sa	Application des inhibiteurs de recapture intestinale des acides biliaires pour la prevention et le traitement de la maladie d'alzheimer
CN102558155A (zh)	2003-01-14	2012-07-11	阿伦纳药品公司	作为代谢调节剂的芳基和杂芳基衍生物及其所涉及的疾病如糖尿病和高血糖症的预防和治疗
GB0304194D0 (en)	2003-02-25	2003-03-26	Astrazeneca Ab	Chemical compounds
GB0314136D0 (en) *	2003-06-18	2003-07-23	Astrazeneca Ab	Therapeutic agents
GB0314134D0 (en) *	2003-06-18	2003-07-23	Astrazeneca Ab	Therapeutic agents
GB0314129D0 (en) *	2003-06-18	2003-07-23	Astrazeneca Ab	Therapeutic agents
AU2004257267B2 (en)	2003-07-14	2009-12-03	Arena Pharmaceuticals,Inc	Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
JP2007512347A (ja) *	2003-11-26	2007-05-17	デューク・ユニバーシティー	緑内障を予防するかまたは治療する方法
MXPA06006829A (es) *	2003-12-15	2006-08-23	Lilly Co Eli	Moduladores del receptor activado por el proliferador selectivo de peroxisoma.
NZ552501A (en) *	2004-08-11	2010-03-26	Kyorin Seiyaku Kk	Novel cyclic aminobenzoic acid derivative
SE0403072D0 (sv) *	2004-12-16	2004-12-16	Astrazeneca Ab	Pharmaceutically useful salts of carboxylic acid derivates
ATE552246T1 (de)	2005-05-31	2012-04-15	Pfizer	Substituierte aryloxy-n- bicyclomethylacetamidverbindungen als vr1- antagonisten
WO2007004957A1 (en) *	2005-07-05	2007-01-11	Astrazeneca Ab	Novel crystalline form
AR055073A1 (es) *	2005-07-11	2007-08-01	Astrazeneca Ab	Agentes terapeuticos
TWI331523B (en) *	2005-12-08	2010-10-11	Nat Health Research Institutes	Vinylsulfonate compounds
CN101054372B (zh) *	2006-04-11	2010-10-13	中国科学院上海药物研究所	嘧啶取代苯丙酸衍生化合物、其制法和在治疗多囊肾疾病中的用途
KR100847780B1 (ko) *	2006-10-26	2008-07-23	재단법인서울대학교산학협력재단	2-에톡시프로피온산 유도체 또는 이의 약학적으로허용가능한 염, 이의 제조방법 및 이를 유효성분으로함유하는 당뇨병 예방 및 치료제
RU2361581C2 (ru)	2007-09-14	2009-07-20	Закрытое Акционерное Общество "Мастерклон"	Фармацевтическая композиция, обладающая противодиабетической, гиполипидемической, гипогликемической и гипохолестеринемической активностью, способ ее получения и способы лечения указанных заболеваний
US20110293549A1 (en)	2009-02-03	2011-12-01	Athena Cosmetics, Inc.	Composition, method and kit for enhancing hair
EA201390421A1 (ru)	2010-09-22	2013-09-30	Арена Фармасьютикалз, Инк.	Модуляторы рецептора gpr119 и лечение связанных с ним нарушений
AU2011326871B2 (en)	2010-11-04	2015-02-12	Albireo Ab	IBAT inhibitors for the treatment of liver diseases
JO3301B1 (ar)	2013-04-26	2018-09-16	Albireo Ab	تعديلات بلورية على إيلوبيكسيبات
KR20220082931A (ko)	2014-06-25	2022-06-17	이에이 파마 가부시키가이샤	고형 제제 및 그의 착색 방지 또는 착색 감소 방법
EP3012252A1 (en)	2014-10-24	2016-04-27	Ferring BV	Crystal modifications of elobixibat
EP4445956A3 (en)	2015-01-06	2024-12-04	Arena Pharmaceuticals, Inc.	Compound for use in treating conditions related to the s1p1 receptor
PL3310760T3 (pl)	2015-06-22	2023-03-06	Arena Pharmaceuticals, Inc.	Krystaliczna sól L-argininy kwasu (R)-2-(7-(4-cyklopentylo-3-(trifluorometylo)benzyloksy)- 1,2,3,4-tetrahydrocyklo-penta[b]indol-3-ilo)octowego do zastosowania w zaburzeniach związanych z receptorem S1P1
US10441605B2 (en)	2016-02-09	2019-10-15	Albireo Ab	Oral cholestyramine formulation and use thereof
US10786529B2 (en)	2016-02-09	2020-09-29	Albireo Ab	Oral cholestyramine formulation and use thereof
US10441604B2 (en)	2016-02-09	2019-10-15	Albireo Ab	Cholestyramine pellets and methods for preparation thereof
CN110520124A (zh)	2017-02-16	2019-11-29	艾尼纳制药公司	用于治疗原发性胆汁性胆管炎的化合物和方法
WO2019032026A1 (en)	2017-08-09	2019-02-14	Albireo Ab	CHOLESTYRAMINE GRANULES, ORAL FORMULATIONS OF CHOLESTYRAMINE AND THEIR USE
EP3802504B1 (en)	2018-06-05	2023-01-18	Albireo AB	Benzothia(di)azepine compounds and their use as bile acid modulators
US10793534B2 (en)	2018-06-05	2020-10-06	Albireo Ab	Benzothia(di)azepine compounds and their use as bile acid modulators
CA3102136A1 (en)	2018-06-06	2019-12-12	Arena Pharmaceuticals, Inc.	Methods of treating conditions related to the s1p1 receptor
US11801226B2 (en)	2018-06-20	2023-10-31	Albireo Ab	Pharmaceutical formulation of odevixibat
MX2020013839A (es)	2018-06-20	2021-03-25	Albireo Ab	Formulacion farmaceutica de odevixibat.
US11007142B2 (en)	2018-08-09	2021-05-18	Albireo Ab	Oral cholestyramine formulation and use thereof
US10722457B2 (en)	2018-08-09	2020-07-28	Albireo Ab	Oral cholestyramine formulation and use thereof
US11549878B2 (en)	2018-08-09	2023-01-10	Albireo Ab	In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US10941127B2 (en)	2019-02-06	2021-03-09	Albireo Ab	Benzothiadiazepine compounds and their use as bile acid modulators
US10975045B2 (en)	2019-02-06	2021-04-13	Aibireo AB	Benzothiazepine compounds and their use as bile acid modulators
DK3921028T3 (da)	2019-02-06	2023-01-23	Albireo Ab	Benzothiadiazepinforbindelser og anvendelse deraf som galdesyremodulatorer
US11014898B1 (en)	2020-12-04	2021-05-25	Albireo Ab	Benzothiazepine compounds and their use as bile acid modulators
CN114761080B (zh)	2019-12-04	2024-07-23	阿尔比里奥公司	苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
CN114786772B (zh)	2019-12-04	2024-04-09	阿尔比里奥公司	苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
CA3158184A1 (en)	2019-12-04	2021-08-10	Albireo Ab	Benzothiadiazepine compounds and their use as bile acid modulators
JP7695242B2 (ja)	2019-12-04	2025-06-18	アルビレオ・アクチボラグ	ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
JP7748451B2 (ja)	2020-08-03	2025-10-02	アルビレオ・アクチボラグ	ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
EP4243831A1 (en)	2020-11-12	2023-09-20	Albireo AB	Odevixibat for treating progressive familial intrahepatic cholestasis (pfic)
KR20230117393A (ko)	2020-12-04	2023-08-08	알비레오 에이비	벤조티아(디)아제핀 화합물 및 담즙산 조절제로서의용도
TW202313579A (zh)	2021-06-03	2023-04-01	瑞典商艾爾比瑞歐公司	苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途
WO2023039276A1 (en) *	2021-09-13	2023-03-16	Curtails Llc	Use of ibat inhibitors and antimicrobials for the treatment of diseases

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE266121C (no)
BE489216A (no)	1948-06-05	1900-01-01
US2928840A (en)	1958-11-26	1960-03-15	Us Vitamin Pharm Corp	3-(o-substituted phenyl) oxazolidinediones and process therefor
GB1081471A (en)	1963-09-13	1967-08-31	Stauffer Chemical Co	Glycol amide derivatives and use thereof in controlling weed growth
US3244398A (en)	1963-10-28	1966-04-05	Scaramucci Domer	Composite seat ball valve
AT307640B (de)	1970-06-18	1973-05-25	Richter Gedeon Vegyeszet	Verfahren zur Herstellung von neuen 17-Aza-steroiden und deren Salzen
BE792364A (fr)	1971-12-06	1973-06-06	Basf Ag	Derives de substitution du sulfonylglycolanilide
DE2349256C2 (de)	1973-10-01	1985-08-01	Basf Ag, 6700 Ludwigshafen	0-Alkylsulfonyl-glykolsäureanilide und diese enthaltende Herbizide
DE2828222A1 (de)	1978-06-28	1980-01-10	Bayer Ag	Gegenmittel zum schutz von kulturpflanzen vor schaedigungen durch herbizide
US4735959A (en)	1981-01-10	1988-04-05	Dr. Karl Thomae Gmbh	Carboxylic acid amides and pharmaceutical compositions containing them
US5216167A (en)	1983-12-30	1993-06-01	Dr. Karl Thomae Gmbh	Phenylacetic acid benzylamides
US5312924A (en)	1983-12-30	1994-05-17	Dr. Karl Thomae Gmbh	Phenylacetic acid benzylamides
US5210208A (en)	1990-09-24	1993-05-11	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Disubstituted aryl compounds exhibiting selective leukotriene b4 antagonist activity
US5958792A (en)	1995-06-07	1999-09-28	Chiron Corporation	Combinatorial libraries of substrate-bound cyclic organic compounds
US6410585B1 (en)	1997-08-28	2002-06-25	Scott D. Larsen	Inhibitors of protein tyrosine phosphatase
WO1999011606A2 (en)	1997-08-28	1999-03-11	Pharmacia & Upjohn Company	Inhibitors of protein tyrosine phosphatase
AU1457299A (en)	1997-11-12	1999-05-31	Ariad Pharmaceuticals, Inc.	Novel signal transduction inhibitors, compositions containing them
SE9801992D0 (sv)	1998-06-04	1998-06-04	Astra Ab	New 3-aryl-2-hydroxypropionic acid derivative I
KR20020060067A (ko)	1999-04-06	2002-07-16	가와무라 요시부미	α-치환 카르복실산 유도체
AU3670900A (en) *	1999-04-08	2000-11-14	Sankyo Company Limited	Substituted fused imidazole derivatives
US6620929B1 (en)	1999-04-14	2003-09-16	University Of British Columbia	1,3-Dipolar cycloadditions to polypyrrolic macrocycles
WO2000063196A1 (en)	1999-04-20	2000-10-26	Novo Nordisk A/S	New compounds, their preparation and use
CN1331862C (zh)	1999-04-28	2007-08-15	萨诺费－阿文蒂斯德国有限公司	作为ppar受体配体的二芳基酸衍生物
JP4618845B2 (ja) *	1999-06-09	2011-01-26	杏林製薬株式会社	ヒトペルオキシゾーム増殖薬活性化受容体（ＰＰＡＲ）αアゴニストとしての置換フェニルプロピオン酸誘導体
TWI262185B (en)	1999-10-01	2006-09-21	Eisai Co Ltd	Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives
JP2001261612A (ja) *	2000-03-22	2001-09-26	Mitsui Chemicals Inc	カテコールプロピオン酸誘導体およびそれを有効成分として含有する核内レセプター作動薬
WO2002044127A1 (fr) *	2000-11-29	2002-06-06	Kyorin Pharmaceutical Co., Ltd.	Dérivés d'acide carboxylique substitué
WO2002044130A1 (fr)	2000-11-29	2002-06-06	Kyorin Pharmaceutical Co., Ltd.	Dérivés d'acide carboxylique substitués
CA2438551A1 (en)	2001-02-15	2002-08-22	Pfizer Products Inc.	Ppar agonists
WO2002083616A1 (en) *	2001-04-10	2002-10-24	Sankyo Company, Limited	α-SUBSTITUTED φ-ARYLFATTY ACID DERIVATIVE
SE0104334D0 (sv) *	2001-12-19	2001-12-19	Astrazeneca Ab	Therapeutic agents
GB0314079D0 (en)	2003-06-18	2003-07-23	Astrazeneca Ab	Therapeutic agents
GB0229931D0 (en)	2002-12-21	2003-01-29	Astrazeneca Ab	Therapeutic agents
CN1662487A (zh)	2002-06-19	2005-08-31	伊莱利利公司	酰胺连接基过氧化物酶体增殖物激活受体调节剂
GB0314136D0 (en)	2003-06-18	2003-07-23	Astrazeneca Ab	Therapeutic agents
GB0314129D0 (en)	2003-06-18	2003-07-23	Astrazeneca Ab	Therapeutic agents
GB0314134D0 (en)	2003-06-18	2003-07-23	Astrazeneca Ab	Therapeutic agents

2001
- 2001-12-19 SE SE0104334A patent/SE0104334D0/xx unknown
2002
- 2002-12-18 PT PT02804964T patent/PT1458673E/pt unknown
- 2002-12-18 IL IL16233102A patent/IL162331A0/xx unknown
- 2002-12-18 WO PCT/GB2002/005738 patent/WO2003051821A1/en not_active Ceased
- 2002-12-18 US US10/499,261 patent/US7514471B2/en not_active Expired - Fee Related
- 2002-12-18 ES ES02788145T patent/ES2286310T3/es not_active Expired - Lifetime
- 2002-12-18 BR BR0214988-5A patent/BR0214988A/pt not_active IP Right Cessation
- 2002-12-18 DK DK02788145T patent/DK1458672T3/da active
- 2002-12-18 AU AU2002366315A patent/AU2002366315A1/en not_active Abandoned
- 2002-12-18 CA CA002470491A patent/CA2470491A1/en not_active Abandoned
- 2002-12-18 TW TW091136518A patent/TWI253444B/zh not_active IP Right Cessation
- 2002-12-18 EP EP02804964A patent/EP1458673B1/en not_active Expired - Lifetime
- 2002-12-18 MX MXPA04006004A patent/MXPA04006004A/es active IP Right Grant
- 2002-12-18 AT AT02788145T patent/ATE363466T1/de not_active IP Right Cessation
- 2002-12-18 UA UA20040604246A patent/UA77460C2/uk unknown
- 2002-12-18 IL IL16233002A patent/IL162330A0/xx unknown
- 2002-12-18 JP JP2003552709A patent/JP3784804B2/ja not_active Expired - Fee Related
- 2002-12-18 NZ NZ533276A patent/NZ533276A/en unknown
- 2002-12-18 NZ NZ533274A patent/NZ533274A/en unknown
- 2002-12-18 RU RU2004116917/04A patent/RU2303031C2/ru not_active IP Right Cessation
- 2002-12-18 SI SI200230424T patent/SI1458673T1/sl unknown
- 2002-12-18 JP JP2003552710A patent/JP3820249B2/ja not_active Expired - Lifetime
- 2002-12-18 HU HU0402022A patent/HUP0402022A3/hu unknown
- 2002-12-18 WO PCT/GB2002/005744 patent/WO2003051822A1/en not_active Ceased
- 2002-12-18 CN CNA028281551A patent/CN1620423A/zh active Pending
- 2002-12-18 SI SI200230570T patent/SI1458672T1/sl unknown
- 2002-12-18 CN CNB028281233A patent/CN1293044C/zh not_active Expired - Fee Related
- 2002-12-18 KR KR10-2004-7009517A patent/KR20040074094A/ko not_active Ceased
- 2002-12-18 UA UA20040604245A patent/UA77987C2/uk unknown
- 2002-12-18 RU RU2004116918/04A patent/RU2300517C2/ru not_active IP Right Cessation
- 2002-12-18 AU AU2002352427A patent/AU2002352427A1/en not_active Abandoned
- 2002-12-18 PL PL02370672A patent/PL370672A1/xx not_active Application Discontinuation
- 2002-12-18 US US10/499,378 patent/US7256307B2/en not_active Expired - Fee Related
- 2002-12-18 CN CNB2006100071731A patent/CN100406427C/zh not_active Expired - Fee Related
- 2002-12-18 EP EP02788145A patent/EP1458672B1/en not_active Expired - Lifetime
- 2002-12-18 HU HU0402133A patent/HUP0402133A3/hu unknown
- 2002-12-18 TW TW091136519A patent/TWI255807B/zh not_active IP Right Cessation
- 2002-12-18 MY MYPI20024740A patent/MY132565A/en unknown
- 2002-12-18 BR BR0214986-9A patent/BR0214986A/pt not_active IP Right Cessation
- 2002-12-18 PL PL02370673A patent/PL370673A1/xx not_active Application Discontinuation
- 2002-12-18 AT AT02804964T patent/ATE338743T1/de not_active IP Right Cessation
- 2002-12-18 CA CA002469302A patent/CA2469302A1/en not_active Abandoned
- 2002-12-18 DK DK02804964T patent/DK1458673T3/da active
- 2002-12-18 MX MXPA04006003A patent/MXPA04006003A/es active IP Right Grant
- 2002-12-18 DE DE60214594T patent/DE60214594T2/de not_active Expired - Lifetime
- 2002-12-18 ES ES02804964T patent/ES2271381T3/es not_active Expired - Lifetime
- 2002-12-18 KR KR10-2004-7009501A patent/KR20040074092A/ko not_active Withdrawn
- 2002-12-18 PT PT02788145T patent/PT1458672E/pt unknown
- 2002-12-18 DE DE60220441T patent/DE60220441T2/de not_active Expired - Fee Related
- 2002-12-19 AR ARP020105002A patent/AR038045A1/es unknown
- 2002-12-19 AR ARP020105004A patent/AR038047A1/es not_active Application Discontinuation
2004
- 2004-06-03 IL IL162330A patent/IL162330A/en not_active IP Right Cessation
- 2004-06-11 ZA ZA200404657A patent/ZA200404657B/en unknown
- 2004-06-11 ZA ZA200404658A patent/ZA200404658B/en unknown
- 2004-06-14 IS IS7309A patent/IS7309A/is unknown
- 2004-06-15 IS IS7313A patent/IS7313A/is unknown
- 2004-07-15 NO NO20043023A patent/NO20043023L/no not_active Application Discontinuation
- 2004-07-16 NO NO20043164A patent/NO20043164L/no not_active Application Discontinuation
2005
- 2005-08-16 JP JP2005235794A patent/JP2005336209A/ja active Pending
2006
- 2006-04-27 JP JP2006123399A patent/JP2006298924A/ja active Pending
- 2006-12-05 CY CY20061101743T patent/CY1106276T1/el unknown
2007
- 2007-08-01 CY CY20071101028T patent/CY1106784T1/el unknown

Also Published As

Publication number	Publication date
IS7309A (is)	2004-06-14
HUP0402133A2 (hu)	2005-02-28
HK1068870A1 (en)	2005-05-06
PL370672A1 (en)	2005-05-30
TWI255807B (en)	2006-06-01
WO2003051821A1 (en)	2003-06-26
RU2300517C2 (ru)	2007-06-10
EP1458673B1 (en)	2006-09-06
CN1620422A (zh)	2005-05-25
US20050171204A1 (en)	2005-08-04
US7514471B2 (en)	2009-04-07
IL162331A0 (en)	2005-11-20
JP3784804B2 (ja)	2006-06-14
WO2003051822A1 (en)	2003-06-26
MXPA04006003A (es)	2004-09-27
ATE363466T1 (de)	2007-06-15
BR0214988A (pt)	2004-12-14
ES2271381T3 (es)	2007-04-16
SI1458672T1 (sl)	2007-10-31
RU2303031C2 (ru)	2007-07-20
US20050113362A1 (en)	2005-05-26
KR20040074094A (ko)	2004-08-21
AR038047A1 (es)	2004-12-22
TW200410918A (en)	2004-07-01
PL370673A1 (en)	2005-05-30
CY1106784T1 (el)	2012-05-23
RU2004116917A (ru)	2005-11-10
HUP0402133A3 (en)	2010-07-28
TW200410925A (en)	2004-07-01
NZ533274A (en)	2005-12-23
CN1620423A (zh)	2005-05-25
ES2286310T3 (es)	2007-12-01
HUP0402022A3 (en)	2009-06-29
CA2469302A1 (en)	2003-06-26
KR20040074092A (ko)	2004-08-21
NZ533276A (en)	2006-04-28
AU2002352427A1 (en)	2003-06-30
JP2005526704A (ja)	2005-09-08
ATE338743T1 (de)	2006-09-15
EP1458672A1 (en)	2004-09-22
DK1458672T3 (da)	2007-09-17
AR038045A1 (es)	2004-12-22
DE60214594T2 (de)	2007-09-13
UA77987C2 (en)	2007-02-15
HK1068604A1 (en)	2005-04-29
US7256307B2 (en)	2007-08-14
EP1458673A1 (en)	2004-09-22
DE60214594D1 (de)	2006-10-19
DE60220441D1 (de)	2007-07-12
RU2004116918A (ru)	2005-11-10
JP3820249B2 (ja)	2006-09-13
IL162330A (en)	2009-06-15
CY1106276T1 (el)	2011-10-12
PT1458672E (pt)	2007-07-18
UA77460C2 (en)	2006-12-15
HUP0402022A2 (hu)	2005-01-28
SE0104334D0 (sv)	2001-12-19
MY132565A (en)	2007-10-31
MXPA04006004A (es)	2004-09-27
JP2005336209A (ja)	2005-12-08
CN1293044C (zh)	2007-01-03
DK1458673T3 (da)	2006-12-11
AU2002366315A1 (en)	2003-06-30
TWI253444B (en)	2006-04-21
JP2006298924A (ja)	2006-11-02
CA2470491A1 (en)	2003-06-26
DE60220441T2 (de)	2008-01-24
IL162330A0 (en)	2005-11-20
ZA200404657B (en)	2005-08-29
IS7313A (is)	2004-06-15
SI1458673T1 (sl)	2007-02-28
CN100406427C (zh)	2008-07-30
PT1458673E (pt)	2006-12-29
CN1896045A (zh)	2007-01-17
NO20043164L (no)	2004-07-16
BR0214986A (pt)	2004-12-14
ZA200404658B (en)	2006-02-22
JP2005526011A (ja)	2005-09-02
EP1458672B1 (en)	2007-05-30

Publication	Publication Date	Title
NO20043023L (no)	2004-07-15	Substituerte fenylpropionsyre-derivater som agonister mot human proliferator-aktivert reseptor alfa (PPAR)
NO20032059D0 (no)	2003-05-08	Peroksisomprolferatoraktiverte reseptoralfa-agonister
DK1492786T3 (da)	2007-02-12	Pyridinoylpiperidiner som 5-HT1F-agonister
ATE537831T1 (de)	2012-01-15	Orale aripiprazol-lösung
NO20030550L (no)	2003-04-04	17<beta>-karbotioat 17<alfa>-arylkarbonyloksyandrostanderivat som anti-inflammatoriske midler
DK1102762T3 (da)	2002-12-16	2-substituerede-1-piperidylbenzimidazolforbindelser som ORL1-receptoragonister
DK1379522T3 (da)	2005-05-30	Dihydro-benzo(b)(1,4)diazeping-2-on-derivater som MGLUR2-antagonister I
NO307168B1 (no)	2000-02-21	Oralt preparat som er effektivt mot halitose
DE60109207T8 (de)	2006-08-24	Orale zusammensetzung
NO20052921D0 (no)	2005-06-15	Fenylsubstituerte piperidinforbindelser for anvendelse som PPAR aktivatorer
NO992470D0 (no)	1999-05-21	2-amidazolinyl-amino-indolforbindelser anvendelige som <alfa>-2-adreno-reseptoragonister
NO20042737L (no)	2004-08-17	Peroksisomproliferatoraktiverte receptoragonister
NO20034497L (no)	2003-10-27	Somatostatin agonister
IL175310A0 (en)	2006-09-05	Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (ppar) dual agonists
DK1355639T3 (da)	2006-08-14	Substituerede carbostyrilderivater som 5-HT1A-receptorsubtypeagonister
DE60326998D1 (de)	2009-05-14	Orale zubereitung
SI1539746T1 (sl)	2007-04-30	Spojine n-substituirane-1h-indol-5-propionske kisline kot agonisti ppar, ki so uporabne za zdravljenje diabetesa
NO20032582D0 (no)	2003-06-06	1,2,4-oksadiazolderivater som HPPAR alfa agonister
NO995030D0 (no)	1999-10-15	5-(2-imidazolinylamino)benzimidazolforbindelser nyttige som <alfa>-2-adrenoseptoragonister
NO20043743L (no)	2004-09-07	Karboksylsyreforbindelser for anvendelse som overflateaktive midler
ES1044077Y (es)	2000-08-16	Dispositivo de accionamiento para la articulacion de reposapies de sillon relax.
ES1052655Y (es)	2003-05-01	Sacacorchos de brazo articulado.
ES1050506Y (es)	2002-08-01	Dispositivo perfeccionado para la sujecion de sombrillas.
ES1051373Y (es)	2002-11-16	Camilla.
NO20006214L (no)	2000-12-07	<alfa>-(1-piperaziny1)acetamidoarenkarboksylsyrederivater som antidiabetiske midler

Legal Events

Date	Code	Title	Description
2010-07-19	FC2A	Withdrawal, rejection or dismissal of laid open patent application
2010-08-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application